Product
OPA-15406
Aliases
1% OPA-15406 Ointment
3 clinical trials
1 indication
Indication
Atopic DermatitisClinical trial
A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Clinical Trial to Demonstrate the Superiority of 0.3% and 1% OPA-15406 Ointment Versus Vehicle in Pediatric Subjects With Atopic DermatitisStatus: Recruiting, Estimated PCD: 2024-11-30
Clinical trial
A Multinational, Multicenter, Randomized, Double-blind, Vehicle-controlled, Parallel-group Comparison Trial to Demonstrate the Superiority of 1% OPA-15406 Ointment to the Vehicle in Adult Patients With Atopic DermatitisStatus: Recruiting, Estimated PCD: 2024-07-31
Clinical trial
A Phase 3, Multicenter, Open-label, Uncontrolled Trial to Evaluate the Efficacy and Safety of OPA-15406 Ointment in Infants Younger Than 2 Years of Age With Atopic DermatitisStatus: Completed, Estimated PCD: 2022-12-29